CIMZIA
Google image searchProduct monograph
Active ingredient
certolizumab pegol, 200 MG/ML
DIN: 02331675
Dosage form(s): SOLUTION
Route(s) of administration: SUBCUTANEOUS
Description: SINGLE-USE PRE-FILLED SYRINGE
Schedule: Prescription / Schedule D
Company: UCB CANADA INC
Date: 31-AUG-2009
ATC:
- L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
- L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
- L04AB — Tumor necrosis factor alpha (TNF-alpha) inhibitors (ATC, ATC/DDD)
- L04AB05 — CERTOLIZUMAB PEGOL (ATC/DDD)
Reference brand drug: Cimzia
